Search research articles
Contact Us
Filters
Showing results (351-360 of 404) with videos related to
Page
of 41
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
October 15, 2008
Anticoagulant drugs in noncompaction: a mandatory therapy?
Giovanni Fazio, Giovanni Corrado, Elisabetta Zachara, et al.
Circulation. Heart Failure
|
January 12, 2018
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study
Iacopo Olivotto, Paolo G Camici, Piera Angelica Merlini, et al.
Journal of the American College of Cardiology
|
March 21, 2015
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis
Tullio Palmerini, Diego Sangiorgi, Marco Valgimigli, et al.
The American Journal of Cardiology
|
July 20, 2014
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy
Elena Biagini, Iacopo Olivotto, Maria Iascone, et al.
European Journal of Heart Failure
|
August 15, 2023
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology
Brenda Moura, Alberto Aimo, Abdallah Al-Mohammad, et al.
Circulation
|
September 16, 2009
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types
Claudio Rapezzi, Giampaolo Merlini, Candida C Quarta, et al.
Heart (British Cardiac Society)
|
October 28, 2018
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis
Constantinos O'Mahony, Mohammed Majid Akhtar, Zacharias Anastasiou, et al.
European Radiology
|
May 11, 2023
Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: a retrospective multicentre study
Anna Palmisano, Chiara Gnasso, Alberto Cereda, et al.
European Journal of Heart Failure
|
May 5, 2022
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis
Aldostefano Porcari, Maddalena Rossi, Francesco Cappelli, et al.
JACC. Cardiooncology
|
November 29, 2022
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
Esther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, et al.
Page
of 41
Search research articles
Search
Showing results (351-360 of 404) with videos related to
Sort By:
Page
of 41
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
October 15, 2008
Anticoagulant drugs in noncompaction: a mandatory therapy?
Giovanni Fazio, Giovanni Corrado, Elisabetta Zachara, et al.
Circulation. Heart Failure
|
January 12, 2018
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study
Iacopo Olivotto, Paolo G Camici, Piera Angelica Merlini, et al.
Journal of the American College of Cardiology
|
March 21, 2015
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis
Tullio Palmerini, Diego Sangiorgi, Marco Valgimigli, et al.
The American Journal of Cardiology
|
July 20, 2014
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy
Elena Biagini, Iacopo Olivotto, Maria Iascone, et al.
European Journal of Heart Failure
|
August 15, 2023
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology
Brenda Moura, Alberto Aimo, Abdallah Al-Mohammad, et al.
Circulation
|
September 16, 2009
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types
Claudio Rapezzi, Giampaolo Merlini, Candida C Quarta, et al.
Heart (British Cardiac Society)
|
October 28, 2018
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis
Constantinos O'Mahony, Mohammed Majid Akhtar, Zacharias Anastasiou, et al.
European Radiology
|
May 11, 2023
Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: a retrospective multicentre study
Anna Palmisano, Chiara Gnasso, Alberto Cereda, et al.
European Journal of Heart Failure
|
May 5, 2022
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis
Aldostefano Porcari, Maddalena Rossi, Francesco Cappelli, et al.
JACC. Cardiooncology
|
November 29, 2022
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
Esther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, et al.
Page
of 41